| Filed On | Filing |
|---|---|
| 02 Nov 2026 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
San Francisco, California – November 2, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update. |
| 21 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
On August 18, 2026, Hinge Health, Inc. (the “Company”) entered into an office lease agreement (the “Lease”) with 50 Beale Street LLC, a Delaware limited liability company (the “Landlord”), for approximately 119,278 rentable square feet l... |
| 04 Aug 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
San Francisco, California – August 4, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2026 and provided a business update. |
| 09 Jun 2026 |
8-K: Regulation FD Disclosure
San Francisco, CA – June 9, 2026 – Tomorrow, June 10, Hinge Health, Inc. (NYSE: HNGE) will host its inaugural Investor Day at Movement - the company’s annual conference that brings employers, health plans, consultants, providers and clin... |
| 04 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On June 3, 2026, Hinge Health, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The Company’s stockholders voted on two proposals at the Annual Meeting, each of which is described below as well as... |
| 05 May 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
San Francisco, California – May 5, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026. |
| 17 Mar 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On March 16, 2026, the Board of Directors (the “Board”) of Hinge Health, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Tyler Sloat to serve as a member of the Board, effecti... |
| 10 Feb 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
San Francisco, California – February 10, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced record financial results for the quarter and year ended December 31, 2025. |
| 12 Nov 2025 |
8-K: Regulation FD Disclosure; Other Events
San Francisco, California – November 12, 2025 – Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. |
| 04 Nov 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
San Francisco, California – November 4, 2025 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2025. |
| 13 Aug 2025 |
8-K: Other Events
In connection with the initial public offering (the “IPO”) of Class A common stock of Hinge Health, Inc. (the “Company”), all of the Company’s directors and executive officers, the selling stockholders in the IPO, and certain other recor... |
| 05 Aug 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
San Francisco, California – August 5, 2025 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2025. |
| 23 May 2025 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Other Events
The address of the registered office of Hinge Health, Inc. (the “Corporation”) in the State of Delaware, and the name of its registered agent at such address, shall be as set forth in the Corporation’s certificate of incorporation, as th... |
Loading...